Amy C. Cavers
Keine laufenden Positionen mehr
Karriereverlauf von Amy C. Cavers
Ehemalige bekannte Positionen von Amy C. Cavers
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELEVATION ONCOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | 01.02.2023 |
Celgene, Inc.
 Celgene, Inc. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases. The Canadian company's portfolio includes several approved products, such as REVLIMID, POMALYST, and OTEZLA, as well as a pipeline of investigational drugs. Celgene is committed to advancing the science of medicine and improving the lives of patients worldwide. | Corporate Officer/Principal | - | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Onyx Therapeutics, Inc.
 Onyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Onyx Therapeutics, Inc. discovers, develops and commercializes novel therapeutics. | Corporate Officer/Principal | - | - |
| TG THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| VERASTEM, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Amy C. Cavers
| University of Arizona | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Celgene, Inc.
Celgene, Inc. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases. The Canadian company's portfolio includes several approved products, such as REVLIMID, POMALYST, and OTEZLA, as well as a pipeline of investigational drugs. Celgene is committed to advancing the science of medicine and improving the lives of patients worldwide. | Health Technology |
Onyx Therapeutics, Inc.
Onyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Onyx Therapeutics, Inc. discovers, develops and commercializes novel therapeutics. | Health Technology |
- Börse
- Insiders
- Amy C. Cavers
- Erfahrung